Application of combination of glycosylated exosome and protein marker in preparation of products for diagnosis or prognosis evaluation of tumors
CN118909945APending Publication Date: 2024-11-08BEIJING FRIENDSHIP HOSPITAL CAPITAL MEDICAL UNIV
Patent Information
- Application Number
- CN202410898421.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-05
- Publication Date
- 2024-11-08
Smart Images

Figure CN118909945A_ABST
Abstract
The invention relates to the technical field of biological medicines, in particular to application of combination of a glycosylated exosome and a protein marker in preparation of a product for diagnosis or prognosis evaluation of tumors. Based on the fact that lectin can recognize and be combined with a specific glycosylation structure, analysis of the glycosylation exosome in a sample is achieved, the lectin comprises one or more than two of CpOGAD298N, DBA or NPA, a protein marker for detecting the glycosylation exosome is combined, a model is built according to protein marker data of the glycosylation exosome by utilizing machine learning, and the specific glycosylation structure can be identified and combined with the lectin. The AUC for the diagnosis or prognosis evaluation of tumors is close to 1.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Application of specific agglutinin compositions to preparation of test carriers for identifying lung cancer types and stages
CN105628934A
Cited By
Lectin chip, EV glycosylation modification detection kit and application thereof
CN119959548A
